MATES SHARON (Chairman, President & CEO) sold 6.1% of their position (70K shares) of INTRA-CELLULAR THERAPIES, INC. on the open market
Open‑market sale worth $5.09M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+35.60K
Price / share
$12.73
Trade value
$453.24K
% of position
Common Stock
Shares
−29.83K
Price / share
$72.44
Trade value
$2.16M
% of position
Common Stock
Shares
−5.77K
Price / share
$73.25
Trade value
$422.77K
% of position
Common Stock
Shares
+34.40K
Price / share
$12.73
Trade value
$437.86K
% of position
Common Stock
Shares
−28.20K
Price / share
$72.73
Trade value
$2.05M
% of position
Common Stock
Shares
−6.19K
Price / share
$73.32
Trade value
$454.09K
% of position
Net shares
+0.00
Net value
-$4.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/29/2024 | M · Option Exercise | +35.60K | $12.73 | $453.24K | 3.3% | 1.07M | 1.11M |
| Common Stock Direct | 8/29/2024 | S · Sale | −29.83K | $72.44 | $2.16M | 2.7% | 1.11M | 1.08M |
| Common Stock Direct | 8/29/2024 | S · Sale | −5.77K | $73.25 | $422.77K | 0.5% | 1.08M | 1.07M |
| Common Stock Direct | 8/30/2024 | M · Option Exercise | +34.40K | $12.73 | $437.86K | 3.2% | 1.07M | 1.10M |
| Common Stock Direct | 8/30/2024 | S · Sale | −28.20K | $72.73 | $2.05M | 2.6% | 1.10M | 1.08M |
| Common Stock Direct | 8/30/2024 | S · Sale | −6.19K | $73.32 | $454.09K | 0.6% | 1.08M | 1.07M |
| Total | +0.00 | -$4.20M | ||||||
Stock Option (right to buy)
Common Stock
35.60K shares
Shares
−35.60K
Strike price
12.73
Held after
137.09K
Exercisable
—
Stock Option (right to buy)
Common Stock
34.40K shares
Shares
−34.40K
Strike price
12.73
Held after
102.70K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock35.60K shares | 8/29/2024 | M · Option Exercise | −35.60K | 12.73 | — | 137.09K |
| Stock Option (right to buy) Direct | Common Stock34.40K shares | 8/30/2024 | M · Option Exercise | −34.40K | 12.73 | — | 102.70K |